Unlike TfR, HER2 is not ubiquitously expressed in all tissues, so the fluorescence signal is restricted to the tumor composed of HER2 overexpressing human breast cancer cells, and occasionally, to some extent, to livers and bladders due to degradation and excretion. Here, ERBB2 is linked to neoplasm.